These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20878402)
21. PET/MRI: a different spin from under the rim. Hicks RJ; Lau EW Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S10-4. PubMed ID: 19104800 [TBL] [Abstract][Full Text] [Related]
22. [Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring]. Schramm N; Schlemmer M; Rist C; Issels R; Reiser MF; Berger F Radiologe; 2010 Apr; 50(4):339-48. PubMed ID: 20221579 [TBL] [Abstract][Full Text] [Related]
23. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659 [TBL] [Abstract][Full Text] [Related]
25. Retrostyloid parapharyngeal space tumors: a clinician and imaging perspective. Varoquaux A; Fakhry N; Gabriel S; Garcia S; Ferretti A; Chondrogiannis S; Rubello D; Taïeb D Eur J Radiol; 2013 May; 82(5):773-82. PubMed ID: 23399040 [TBL] [Abstract][Full Text] [Related]
26. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Wehrl HF; Judenhofer MS; Wiehr S; Pichler BJ Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S56-68. PubMed ID: 19194703 [TBL] [Abstract][Full Text] [Related]
27. Sixth Annual Mario S. Verani, MD Memorial Lecture: Cardiovascular imaging--added value or added cost? Bonow RO J Nucl Cardiol; 2008; 15(2):170-7. PubMed ID: 18371587 [No Abstract] [Full Text] [Related]
28. Multimodality imaging: an update on PET/CT technology. Mawlawi O; Townsend DW Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S15-29. PubMed ID: 19104808 [TBL] [Abstract][Full Text] [Related]
29. A look ahead: PET/MR versus PET/CT. von Schulthess GK; Schlemmer HP Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S3-9. PubMed ID: 19104804 [TBL] [Abstract][Full Text] [Related]
30. Use of PET/CT to evaluate response to therapy in lymphoma. Zanoni L; Cerci JJ; Fanti S Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583 [TBL] [Abstract][Full Text] [Related]
31. Imaging technology of the future. Persson A Br J Surg; 2006 Oct; 93(10):1182-4. PubMed ID: 16983739 [No Abstract] [Full Text] [Related]
32. Imaging of atherosclerosis: can molecular imaging do more? Lairez O; Fayad ZA Arch Cardiovasc Dis; 2013 Nov; 106(11):551-3. PubMed ID: 23927996 [No Abstract] [Full Text] [Related]
33. Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging. Bala G; Cosyns B Curr Cardiol Rep; 2014 Sep; 16(9):520. PubMed ID: 25059464 [TBL] [Abstract][Full Text] [Related]
34. The aging of the heart and blood vessels: a consideration of anatomy and physiology in the era of computed tomography, magnetic resonance imaging, and positron emission tomographic imaging methods with special consideration of atherogenesis. Botvinick EH; Perini R; Bural G; Chen W; Chryssikos T; Houseni M; Hernandez-Pampaloni M; Torigian DA; Alavi A Semin Nucl Med; 2007 Mar; 37(2):120-43. PubMed ID: 17289459 [TBL] [Abstract][Full Text] [Related]
35. The year in cardiac imaging. Gibbons RJ; Araoz PA; Williamson EE J Am Coll Cardiol; 2011 Apr; 57(17):1721-34. PubMed ID: 21511108 [No Abstract] [Full Text] [Related]
36. [Positron emission tomography/computed tomography (PET/CT): present and future of a new imaging technique in oncology]. Gámez C Cir Esp; 2005 Mar; 77(3):111-3. PubMed ID: 16420900 [No Abstract] [Full Text] [Related]
37. Clinical molecular imaging with PET agents other than 18F-FDG. Hall LT; Struck AF; Perlman SB Curr Pharm Biotechnol; 2010 Sep; 11(6):545-54. PubMed ID: 20420567 [TBL] [Abstract][Full Text] [Related]
38. [Imaging of paranasal sinuses today]. Dammann F Radiologe; 2007 Jul; 47(7):576, 578-83. PubMed ID: 18080371 [TBL] [Abstract][Full Text] [Related]
39. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371 [TBL] [Abstract][Full Text] [Related]
40. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go. Herrmann K; Benz MR; Krause BJ; Pomykala KL; Buck AK; Czernin J Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):620-32. PubMed ID: 22231582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]